statistiche ricercatore

Continente	#
EU - Europa	754
NA - Nord America	531
AS - Asia	318
SA - Sud America	63
AF - Africa	11
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.680

Nazione	#
US - Stati Uniti d'America	519
DE - Germania	279
IT - Italia	157
SG - Singapore	132
SE - Svezia	94
CN - Cina	74
FR - Francia	54
BR - Brasile	51
GB - Regno Unito	42
UA - Ucraina	37
JP - Giappone	34
IN - India	21
PL - Polonia	18
IE - Irlanda	16
RU - Federazione Russa	13
VN - Vietnam	13
FI - Finlandia	11
CA - Canada	10
ID - Indonesia	10
HK - Hong Kong	9
NL - Olanda	9
BE - Belgio	7
IQ - Iraq	6
MA - Marocco	6
AR - Argentina	5
HU - Ungheria	5
BD - Bangladesh	4
JO - Giordania	3
VE - Venezuela	3
ZA - Sudafrica	3
AT - Austria	2
EC - Ecuador	2
KR - Corea	2
LT - Lituania	2
LV - Lettonia	2
NZ - Nuova Zelanda	2
A2 - ???statistics.table.value.countryCode.A2???	1
AZ - Azerbaigian	1
BY - Bielorussia	1
BZ - Belize	1
CI - Costa d'Avorio	1
CO - Colombia	1
CV - Capo Verde	1
CZ - Repubblica Ceca	1
IL - Israele	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MM - Myanmar	1
MX - Messico	1
MY - Malesia	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
TR - Turchia	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	1.680

Nome	#
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives	333
Le infezioni delle vie urinarie	223
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene)	207
The occult urothelial cancer	171
Bladder and prostate metastasis from small cell lung cancer: a rare entity	148
Imaging in prostate cancer staging: present role e future perspectives	141
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes	130
Local relapse of prostate cancer after primary definitive treatment: the management	122
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes	120
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer	105
Totale	1.700

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	69	0	0	0	0	0	8	13	3	15	8	19	3
2021/2022	157	12	8	2	12	9	3	18	21	15	11	18	28
2022/2023	297	42	40	22	49	13	37	15	23	29	6	12	9
2023/2024	126	6	26	4	18	10	15	4	12	2	2	14	13
2024/2025	239	11	12	22	12	27	35	2	12	15	24	37	30
2025/2026	245	74	5	16	49	83	18	0	0	0	0	0	0
Totale													1.700

IRIS UniCatt